Search Results

You are looking at 1 - 2 of 2 items for

  • Author: Yutaka Suzuki x
Clear All Modify Search
Full access

Hiroyuki Watanabe, Hiroshi Suzuki and Yutaka Fukui

The aim of the present study was to investigate the safety of sperm pre-treatment during the ICSI procedure using a mouse model. Mouse spermatozoa were treated with methyl-β-cyclodextrin, lysolecithin, Triton X-100, and dithiothreitol (DTT), and injected into mouse oocytes. The injected oocytes were monitored for chromosomal integrity and pre- and post-implantation development. The chromosomal integrity of the injected oocytes was impaired by in vitro incubation and chemical antagonism. Particularly in the 60-min DTT group, severe chromosome damage increased. Despite the chromosomal damage, the resultant embryos frequently developed to the blastocyst stage. However, the embryos in the 60-min DTT group had significantly higher chromosomal damage and decreased developmental competence to live fetuses. These results indicate that excessive sperm pre-treatment such as DTT for 60 min generates severe chromosome damage in injected oocytes, and that the damage decreases developmental competence to live fetuses but not to blastocysts.

Full access

Yu Chen, Hongshi Yu, Andrew J Pask, Asao Fujiyama, Yutaka Suzuki, Sumio Sugano, Geoffrey Shaw and Marilyn Renfree

The development of the mammalian phallus involves hormone-dependent mesenchymal-epithelial signalling mechanisms that contribute to urethral closure and regulation of phallus elongation and growth. In marsupials, most differentiation and growth of the phallus occurs post-natally, making them amenable to direct hormone treatment. Expression of IGFs, FGFs, EFNB2, MAFB, DLX5 and AP-1 mRNAs in the phallus at day 50 post-partum (pp) were altered after treatment of tammar wallaby young from day 20-40 pp with androgen, oestrogen or after castration at day 25pp. However, the most interesting changes occurred in the IGF pathway genes. Androgen treatment upregulated IGF1 in female phalluses and oestrogen treatment upregulated IGF1 in male phalluses, but it was downregulated by castration. IGFBP3 was higher in female phalluses and downregulated by androgen. IGF1 expression was higher in all untreated male than in female phalluses from day 50 to 150 pp, but IGFBP3 had the reverse pattern. At day 90 pp, when urethral closure in males is progressing and male phallus growth is accelerating. IGF1 and PCNA protein were only detected in the male urorectal septum, suggesting for the first time that closure and elongation may involve IGF1 activation of cell proliferation specifically in male phalluses. These effects of sex steroids on gene expression, and on the IGF1 signalling pathway in particular, suggest that the developing phallus may be especially susceptible to perturbation by exogenous hormones.